Eligard for Prostate Cancer
The U.S. Food and Drug Administration (FDA) has approved Eligard® (leuprolide acetate) for prostate cancer. Specifically, this medication is used to treat disease that has spread beyond the prostate and is therefore considered to be in an advanced state. Eligard can help slow down the disease's progression and provide relief from symptoms; however, it is not a cure.
Although Eligard is used primarily for prostate cancer, it does have some unapproved ("off-label") uses. These include the treatment of breast or ovarian cancer, among other things.
(To learn more about how this drug works for prostate cancer, whether it can be prescribed for children, and other possible off-label uses, click Eligard Uses.)